Leo Pharma

This study tested if a higher dose of the drug brodalumab works better for people with moderate-to-severe plaque psoriasis who weigh 120 kg (265 lbs) or more. It involved 385 adults and compared the standard treatment to an increased dosage given by injection every two weeks. The…

This study tested whether tralokinumab injections every two weeks could safely improve moderate-to-severe atopic hand eczema in adults. 235 participants received either the drug or placebo injections for 16 weeks, then all received the drug for another 16 weeks. Researchers measu…

This study tested a cream called delgocitinib for people with moderate to severe chronic hand eczema that didn't improve enough with standard steroid creams. Over 360 Chinese adults and teenagers applied the cream twice daily for 16 weeks to see if it could clear or nearly clear …

This completed study tested four different doses of an experimental drug called LEO 138559 (temtokibart) against a placebo in 262 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to find the most effective and safest dose to reduce the severity and extent o…

This was a very small, early-stage study to see if a single injection of an experimental drug called LEO 158968 could safely reduce pain from sudden gout attacks. It involved just 6 people who were experiencing a painful gout flare in one of their joints. The main goal was to che…